Skip to main content
Healthcare

STAT+: With $173 million, new startup takes aim at sickle cell

STAT+: With $173 million, new startup takes aim at sickle cell

Feed excerpt — reported by STAT News

Researchers are seeking a sickle cell treatment as effective as gene therapy, without the drawbacks. This entrepreneur thinks he might have one.

MAP records observable characteristics of the original article (publisher, author, date, references, framing cues). MAP does not verify the article’s claims or score it. Read the full original story at STAT News →

Original Source

This article was syndicated from STAT News. All rights remain with the original publisher.